glp 1 cancer prevention Dr Frontiers | Reassessing cancer risk
Description
Chris Serres: I
A common approach to enhance the therapeutic benefits of GLP-1-based pharmacology is therefore to improve its pharmacokinetics
Ketema EB, Lopaschuk GD
[DOI] [PubMed] [Google Scholar] 64.Bradley M., Melchor J., Carr R., Karjoo S
however, intriguing hypotheses emerge from single cell RNA sequencing data in rodents
GLP-1RAs represent an important drug class for the treatment of T2D and offer marked reductions in plasma glucose levels with a low risk of hypoglycaemia, body weight reductions and a reduction in CVD in patients with high CVD risk
